Tracking daily fatigue fluctuations in multiple sclerosis:ecological momentary assessment provides unique insights by Powell, Daniel J H et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Powell, D. J. H., Liossi, C., Schlotz, W., & Moss-Morris, R. (2017). Tracking daily fatigue fluctuations in multiple
sclerosis: ecological momentary assessment provides unique insights. Journal of Behavioral Medicine, 772–783.
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
Tracking daily fatigue fluctuations in multiple sclerosis: ecological
momentary assessment provides unique insights
Daniel J. H. Powell1,2 • Christina Liossi2 • Wolff Schlotz2,3 • Rona Moss-Morris2,4
Received: August 12, 2016 /Accepted: February 28, 2017 / Published online: March 9, 2017
 The Author(s) 2017. This article is published with open access at Springerlink.com
Abstract Studies investigating the prevalence, cause, and
consequence of multiple sclerosis (MS) fatigue typically
use single measures that implicitly assume symptom-sta-
bility over time, neglecting information about if, when, and
why severity fluctuates. We aimed to examine the extent of
moment-to-moment and day-to-day variability in fatigue in
relapsing-remitting MS and healthy individuals, and iden-
tify daily life determinants of fluctuations. Over 4 week-
days, 76 participants (38 relapsing-remitting MS; 38
controls) recruited from multiple sites provided real-time
self-reports six times daily (n = 1661 observations ana-
lyzed) measuring fatigue severity, stressors, mood, and
physical exertion, and daily self-reports of sleep quality.
Fatigue fluctuations were evident in both groups. Fatigue
was highest in relapsing-remitting MS, typically peaking in
late-afternoon. In controls, fatigue started lower and
increased steadily until bedtime. Real-time stressors and
negative mood were associated with increased fatigue, and
positive mood with decreased fatigue in both groups.
Increased fatigue was related to physical exertion in
relapsing-remitting MS, and poorer sleep quality in con-
trols. In relapsing-remitting MS, fatigue fluctuates sub-
stantially over time. Many daily life determinants of
fluctuations are similar in relapsing-remitting MS and
healthy individuals (stressors, mood) but physical exertion
seems more relevant in relapsing-remitting MS and sleep
quality most relevant in healthy individuals.
Keywords Multiple sclerosis  Fatigue  Ecological
momentary assessment  Ambulatory assessment 
Psychological stress  Affect
Introduction
Approximately 65–80% of people with multiple sclerosis
(MS) experience severe fatigue (Hadjimichael et al., 2008;
Lerdal et al., 2003; Minden et al., 2006). Fatigue is usually
assessed in research and clinical practice by asking patients
to provide recalled summaries of severity or impact over a
period of time (Tyson & Brown, 2014). However, this
implicitly assumes symptom-constancy over the time per-
iod, overlooking potentially important information about
day-to-day, moment-to-moment, and context-dependent
fluctuations. We present the first prospective quantitative
study to determine the extent of within-person fatigue
fluctuations in MS in daily life, examining temporal and
contextual determinants of fatigue severity in people with
relapsing-remitting MS and healthy individuals in daily
life.
MS fatigue is commonly defined as ‘‘a subjective lack of
physical and/or mental energy that is perceived by the
individual or caregiver to interfere with usual and desired
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activities’’ (Multiple Sclerosis Council for Clinical Practice
Guidelines, 1998, p. 2). Fatigue is considered a subjective
sensation, with objective changes in mental or physical
performance conceptualized as fatigability (Kluger et al.,
2013). The pathology of MS fatigue is poorly understood,
and fatigue is commonly thought to emanate from both
primary (centrally-mediated disease factors) and secondary
(all other factors) sources (Kos et al., 2008). Neurological
symptoms, depressive symptoms, and sleep disturbance
have been found to independently contribute to overall
variance in fatigue in MS (Strober & Arnett, 2005) and
others have noted multiple other sources of fatigue in MS,
including psychosocial stress, unhealthy lifestyles, and
physical exertion (Mills & Young, 2008).
Initial insights into the everyday dynamics of MS fati-
gue have implied a fluctuating symptom, with qualitative
and, small clinic-based, quantitative studies suggesting
fatigue is typically worst in the latter part of the day
(Claros-Salinas et al., 2010; Feys et al., 2012; Freal et al.,
1984; Mills & Young, 2008; Morris et al., 2002) and is
exacerbated by psychosocial stress (Mollaog˘lu & U¨stu¨n,
2009; Stuifbergen & Rogers, 1997). It remains unclear
whether fatigue in MS has a unique pattern of relationships
with stress and mood-disturbance, or whether it mirrors
associations also found in healthy individuals (Gledhill,
2005). Although physical (in)activity and sleep are con-
sidered relevant to MS fatigue (Strober, 2015; Stroud &
Minahan, 2009) the immediacy of their effects is poorly
understood.
The present study investigated day-to-day and moment-
to-moment fluctuations in fatigue severity in people with
relapsing-remitting MS and healthy individuals. Based on
previous studies, we expected fatigue to vary significantly
within-individuals in relapsing-remitting MS. Controlling
for baseline depressive symptoms and chronic stress, we
expected fatigue severity to increase across the day in
relapsing-remitting MS, at a faster rate than in controls. We
also expected fatigue to vary within-individuals, in both
groups, with poorer sleep quality, physical exertion, psy-
chosocial stress, and negative mood (independent of posi-
tive mood), whilst varying inversely with positive mood
(independent of negative mood).
Method
This article presents a first analysis of real-time self-report
data collected within an investigation of associations
between cortisol and fatigue in relapsing-remitting MS,
published elsewhere (Powell et al., 2015).
Participants
Between February 2012 and February 2013, 42 people with
clinically-definite relapsing-remitting MS (Polman et al.,
2011) as determined by a neurologist, and 40 healthy
individuals well-matched for age and gender were recrui-
ted. Eligibility criteria are outlined in Table 1. The
relapsing-remitting MS group was recruited from multiple
sites: consecutive eligible patients at neurologist and spe-
cialist nurse clinics at University Hospital Southampton
NHS Foundation Trust and Guy’s and St Thomas’ NHS
Foundation Trust, and nearby MS Society networks. Once
an individual was recruited to the MS group, an individual
of the same gender and similar age (±3 years) was
recruited to the healthy control group from the local
community (Hampshire and Greater London). Of those
patients referred to participate in the study, 76 of 205
(37%) were eligible, of which 42 (55%) took part. The
control group (40 of 55 invited; 72%) was recruited from
Table 1 Participant recruitment eligibility criteria
Relapsing-remitting MS group Healthy control group
Inclusion criteria:
A clinically-definite diagnosis of relapsing-remitting MS (Polman et al., 2011)
Aged 18–65 years
Inclusion criteria
Healthy individual
Aged 18–65 years
Exclusion criteria:
A recent (within 3 months) clinical relapse or corticosteroid treatment
An inability to ambulate 300 metres without rest
An additional physical or psychiatric diagnosis
A high level of depressive symptoms [scoring C 8 on the depression
subscale of the Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983)]
Current prescription of antidepressant medication
Currently pregnant
Shift-worker
Caregiver
Exclusion criteria:
A current chronic or acute disease or illness
A current prescription for any medication
Currently pregnant
Shift-worker
Caregiver
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local postings in Hampshire and Greater London. Data
from four participants were lost to technical faults or a
discovered endocrine abnormality, and two participants
withdrew prior due to unrelated illness or personal reasons,
leaving 38 individuals in each group.
Ethical approval was granted by the UK NHS National
Research Ethics Service Committee (11/SC/0333) and the
University of Southampton Psychology Ethics Committee.
All data included in this manuscript were obtained in
compliance with University of Southampton regulations
and the Helsinki Declaration. All participants gave written
informed consent and, upon completion of the study,
received £40 reimbursement for their time and expenses.
Baseline and training
One-to-one introductory sessions with the researcher took
place at the University of Southampton or King’s College
London. Here, participants provided demographic infor-
mation, completed baseline questionnaires, and received
training in the electronic handheld device used to prompt
the ecological momentary assessment schedule (Shiffman
et al., 2008).
Ecological momentary assessment schedule
Ecological momentary assessment is defined as the rela-
tively intensive and repeated assessment of variables in
real-time, in the real-world, as individuals go about their
usual daily activities (Shiffman et al., 2008). Ecological
momentary assessment was used to collect repeated real-
time measurements of fatigue severity and psychosocial
determinants, over time, in daily life. Ecological momen-
tary assessment was delivered via handheld device (Hew-
lett Packard iPAQ 111 Classic Handheld) using software
programmed with Microsoft Visual Studio. Over 4 con-
secutive weekdays, real-time self-reports were prompted
by auditory alarm six times per day between 10 am and
8 pm by an algorithm randomly assigning a single prompt
within each of six consecutive 100-min periods, with inter-
prompt periods of at least 30 min. Participants could
postpone responses for 5, 10, or 15 min, and select a silent
mode if required. The quasi-random design limits the
biases associated with fixed time designs ensuring a rep-
resentative sample of daily life. A final auditory prompt at
9 pm requested a recall measure.
Measures
Baseline measures
Fatigue severity Participants completed the 11-item
Chalder Fatigue Questionnaire (Chalder et al., 1993) which
is considered a valid and reliable measure of fatigue
severity in MS (Chilcot et al., 2015). Chalder Fatigue
Questionnaire scores range from 0 to 33, with higher scores
indicate greater fatigue severity over the last month (pre-
sent study Cronbach a = .65).
Covariates Participants completed the 7-item depression
subscale from the Hospital Anxiety and Depression Scale
(Zigmond & Snaith, 1983) which has been shown to be a
valid measure for depression in MS (Honarmand & Fein-
stein, 2009). Higher subscale scores (possible range: 0–21)
indicate high levels of depressive symptoms over the prior
week (a = .65). The 12-item Chronic Stress Screening
Scale (Schulz et al., 2004) was completed, with higher
scores indicating greater chronic stress over the previous
3 months (a = .91). Chronic Stress Screening Scale scores
range from 0 to 48, and this is the first time this measure
has been used in MS. Neurological disability in MS was
measured by the self-administered Expanded Disability
Status Scale (Bowen et al., 2001) incorporating a series of
bespoke items covering a spectrum of functioning.
Expanded Disability Status Scale scores range from 0 to
10, with higher scores indicating greater disability. The
self-administered Expanded Disability Status Scale corre-
lates highly with the physician-delivered Expanded Dis-
ability Status Scale (Kurtzke, 1983).
Ecological momentary assessment measures
Momentary fatigue severity All ecological momentary
assessment measures are shown in full in Supplementary
Materials 1. Real-time Momentary Fatigue Severity was
measured by a single item: ‘How much fatigue (tiredness,
weariness, problems thinking clearly) do you feel right
now?’ with responses from 0 ‘None at all’ to 10 ‘Extreme
Fatigue’. This item was based on the ‘Right Now’ item
from the Brief Fatigue Inventory (Mendoza et al., 1999)
with ‘problems thinking clearly’ added to reflect mental
fatigue (Multiple Sclerosis Council for Clinical Practice
Guidelines, 1998). Convergent validity was demonstrated
by strong, negative, within-person associations with ‘En-
ergetic’ (c = -0.53, p\ .001) and ‘Alert’ (c = -0.47,
p\ .01) items, and discriminant validity by weak associ-
ations with ‘Anxious’ (c = 0.18, p = .33) and ‘Distressed’
(c = 0.08, p = .74) items.
Momentary stressor exposure Eight items assessing real-
time daily life stress were based on domains of the Trier
Inventory for Chronic Stress (Schulz et al., 2004). All items
(e.g., ‘I did a lot of work’) were prefixed by ‘Since the last
event…’ (i.e., last alarm) and responses were from 0 ‘Not
774 J Behav Med (2017) 40:772–783
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at all’ to 10 ‘Very much so’. An exploratory factor analysis
found three factors (Supplementary Materials 2). Due to
the limited within-subject reliabilities (Geldhof et al.,
2014) of these factor scores identified by the factor anal-
ysis, these were discarded in favor of testing the unique
effects of each stressor item in exploratory models.
Momentary mood Fifteen mood adjectives (e.g., ‘Irrita-
ble’) used in a previous study by our research group
(Powell & Schlotz, 2012) were prefixed by ‘At the
moment, I feel…’ with responses from 0 ‘Not at all’ to 10
‘Very much so’. An exploratory factor analysis (Supple-
mentary Materials 2) yielded two independent factors:
Negative Mood (10 items) and Positive Mood (5 items).
Scale scores were computed as the mean of items and
demonstrated satisfactory within-subject reliabilities (NA:
xwithin = .86; PA: xwithin = .68).
Daily life behaviors Participants provided real-time self-
reports, prefixed by ‘In the last 30 min…’, for physical
exertion, napping, smoking, having a meal, and drinking
coffee (‘yes’/‘no’ responses). Sleep quality was rated upon
awakening by ‘How would you rate the quality of your
sleep last night?’ from 0 ‘Very bad’ to 10 ‘Very good’.
Daily fatigue severity Recalled Daily Fatigue Severity
was measured at 9 pm by a single item: ‘How much fatigue
(tiredness, weariness, problems thinking clearly) have you
felt today?’ with responses from 0 ‘None at all’ to 10
‘Extreme Fatigue’.
Statistical analysis
Group comparisons for baseline measures and person-mean
real-time and daily assessments used t-tests and Mann–
Whitney U tests. Person-mean refers to the mean average
for a single individual. A bivariate Spearman’s rank cor-
relation matrix examined the relatedness of the different
temporal measures of fatigue severity (Chalder Fatigue
Questionnaire, person-mean Daily Fatigue Severity, per-
son-mean Momentary Fatigue Severity) and their respec-
tive associations with Depression subscale, Chronic Stress
Screening Scale, and Expanded Disability Status Scale.
To appropriately test our main hypotheses, 3-level
multilevel models were used that nested Momentary Fati-
gue Severity assessments within days, within individuals.
Multilevel modelling was deemed most appropriate as it
accounts for nested data and permits unequally spaced
assessments, whilst robust to missing data (Black et al.,
2012; Singer & Willett, 2003). The models used maximum
likelihood estimation to account for missing data that
showed no discernable pattern, suggesting these data were
missing at random. Null model residuals indicated the
proportion of the overall variability in fatigue that was
attributable to each of the three levels: moment-to-moment
fluctuations, day-to-day fluctuations, and individual dif-
ferences. Diurnal fatigue patterns (the typical pattern over
time for each group) were assessed by adding linear and
quadratic fixed and random time effects, with fixed group
and group-by-time interaction effects. Potential covariates
(napping, smoking, caffeine, age, gender) were tested, with
statistically significant covariates retained in the final
model. Fixed effects of the Depression subscale and
Chronic Stress Screening Scale scores were entered into
final models (Model A; Supplementary Materials 3) with
Expanded Disability Status Scale score also entered where
the relapsing-remitting MS group was comparator.
In order to test the effects of mood and stress, several
models were run, based on Model A, with real-time pre-
dictors (behaviors, stressors, mood) added as fixed effects
with interactions with group to detect group differences in
their effects (Models B–D; see Supplementary Materials
3). Model B included physical exertion and sleep quality as
predictors; Model C, the eight stressor items; and Model D,
the two mood factors. Random effects of statistically sig-
nificant predictors were then entered into each model to test
whether these effects varied substantially across people. In
all models, baseline predictors were centered about the
grand-mean (i.e., extent an individual scored above/below
the average level across all participants). Real-time
covariates and predictors were person-mean centered for
within-person analysis (i.e., extent a real-time rating was
above/below an individual’s usual level). Time was cen-
tered at 10am. Analyses used SPSS Version 23. The cri-
terion for statistical significance was a = .05.
Results
Analysis was based on 1661 completed assessments
(90.9% of scheduled in the relapsing-remitting MS group;
91.2% in control group) across 304 days, within 76 par-
ticipants (38 relapsing-remitting MS; 38 control). Table 2
shows group comparisons for baseline and ecological
momentary assessment measures. The relapsing-remitting
MS group had higher average Momentary Fatigue Severity,
d = 1.30, 95% CI [0.80, 1.79] and Daily Fatigue Severity,
d = 1.44, 95% CI [0.93, 1.93] than the control group. The
person-means of two types of stressor (Excessive Demands;
Social Isolation) and Negative Mood were significantly
higher in the relapsing-remitting MS group. Positive Mood
was only marginally lower in the relapsing-remitting MS
group.
Table 3 shows high correlations between person-mean
Momentary Fatigue Severity and Daily Fatigue Severity in
both the relapsing-remitting MS group and control group.
J Behav Med (2017) 40:772–783 775
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Person-mean Momentary Fatigue Severity and Daily Fati-
gue Severity had the strongest correlations with the Chalder
Fatigue Questionnaire in the relapsing-remitting MS group
whilst not statistically significant in the control group.
Extent of fatigue fluctuations
In the relapsing-remitting MS group, 35.2% of all observed
variability in fatigue severity was attributed to moment-to-
moment fluctuations, 8.2% to day-to-day changes, and
56.6% to individual differences. This was relatively similar
to the 43.5% (moment-to-moment), 14.1% (day-to-day),
and 42.3% (individual differences) in controls. To
demonstrate the potential utility and unique information
provided by within-person outcomes computed from real-
time data, Fig. 1 presents single-case data from three
individuals with relapsing-remitting MS with similar mean
ratings but vastly different patterns of fatigue indicated by
respective within-person patient reported outcomes (Jahng
et al., 2008; Stone et al., 2012).
Table 2 Demographic and clinical characteristics of recruited sample
Relapsing-remitting MS Control p
n 38 38
Age 41.89 (7.53) 40.34 (8.16)
Gender 31F 31F
Employment
Paid employment 30 33
Unpaid employment 3 1
Unemployed 5 4
Expanded Disability Status Scale 4.29 (1.37)
Years since diagnosis 6.03 (5.18)
Disease modifying therapy (DMT)
Interferon 12
Glatiramer acetate 6
Natalizumab 5
No DMT 15
HADS-depression 4.00 (2.29) 2.08 (2.27) \.001
Chronic Stress Screening Scale 19.82 (9.36) 14.11 (7.93) .006
Chalder Fatigue Questionnaire 17.58 (7.09) 11.55 (2.87) \.001
Ecological Momentary Assessments (average of person-means)
Fatigue severity
Momentary fatigue severity 5.07 (2.30) 2.42 (1.72) \.001
Daily fatigue severity 4.74 (2.27) 1.80 (1.77) \.001
Stressor exposure
Work overload 4.55 (1.45) 5.20 (1.80) .098
Social overload 4.32 (2.26) 4.02 (2.04) .68
Excessive demands at work 2.00 (1.31) 1.31 (1.22) .023
Lack of social recognition 1.98 (1.87) 1.15 (1.33) .050
Work discontent 2.70 (1.96) 2.78 (2.04) .86
Social tensions 0.95 (1.02) 0.70 (0.88) .33
Pressure to perform 3.93 (1.87) 3.45 (2.49) .39
Social isolation 6.62 (2.25) 5.42 (2.30) .018
Mood
Negative mood 2.12 (1.15) 1.48 (1.35) .008
Positive mood 4.91 (1.60) 5.65 (1.63) .079
Behavioural
Sleep quality 6.07 (1.57) 6.22 (1.97) .72
Physical exertion (n reported bouts daily) 0.45 (0.69) 0.32 (0.48) .30
Mean (SD) shown for all continuous variables. HADS indicates Hospital Anxiety and Depression Scale
776 J Behav Med (2017) 40:772–783
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Typical diurnal fatigue pattern
Table 4 shows Momentary Fatigue Severity ratings were,
on average, 1.80 units higher at 10 am in the relapsing-
remitting MS group than the control group (p\ .001) after
controlling for Depression subscale and Chronic Stress
Screening Scale scores. Momentary Fatigue Severity typi-
cally increased with time in both groups, but with different
temporal patterns (see Fig. 2): in relapsing-remitting MS,
fatigue increased, on average, by 0.49 units per hour (linear
effect; p\ .001) but simultaneously decreased by 0.03
units per hour squared (quadratic effect; p = .012); in
controls, fatigue increased by 0.27 units per hour (linear
effect; p = .015).1 Random linear time effects were sta-
tistically significant indicating that, despite finding a robust
typical diurnal fatigue pattern in the relapsing-remitting
MS group, patterns differed substantially both from indi-
vidual-to-individual and from day-to-day. The inclusion of
time effects reduced residual variance such that 45.5% of
moment-to-moment fatigue fluctuations across both groups
were explained by time of day (42.7% in relapsing-remit-
ting MS group only). Diurnal fatigue patterns remained
substantially unchanged in a sensitivity analysis including
no covariates, and also in a sensitivity analysis including
employment status and disease modifying therapies as
additional covariates.
Contextual correlates in daily life
Table 5 shows physical exertion in the prior 30 min was
associated with an average 1.00-unit increase in Momen-
tary Fatigue Severity in the relapsing-remitting MS group
(p\ .001) but was not associated with Momentary Fatigue
Severity in controls. Sleep quality was not associated with
Momentary Fatigue Severity in the relapsing-remitting MS
group, but in controls, when sleep quality was 1 SD lower
than the person-mean (i.e., than usual for that person), there
was an average 0.30-unit increase in Momentary Fatigue
Table 3 Nonparametric bivariate correlation matrix of fatigue severity measures, momentary mood, depressive symptoms, chronic stress, and
neurological symptoms in people with relapsing-remitting MS and healthy controls
Fatigue severity measures Momentary mood (diary) Baseline covariates
MomFSa DailyFSa CFQ NMa PMa HADS-D CSSS
Mean SD rs p rs p rs p rs p rs p rs p rs p
Relapsing-remitting MS group
MomFSa 5.07 2.30
DailyFSa 4.74 2.27 .782 \.001
CFQ 17.58 7.09 .540 \.001 .559 \.001
NMa 2.12 1.15 .290 .078 .320 .050 .148 .37
PMa 4.91 1.60 -.376 .020 -.375 .020 -.233 .16 -.228 .17
HADS-D 4.00 2.29 .164 .33 .283 .085 .086 .61 .093 .58 -.267 .11
CSSS 19.82 9.36 .394 .014 .372 .022 .077 .65 .242 .14 -.246 .14 .141 .40
EDSSb 4.29 1.37 .356 .028 .420 .009 .327 .045 .194 .24 -.470 .003 .421 .009 .318 .051
Control group
MomFSa 2.42 1.72
DailyFSa 1.80 1.77 .764 \.001
CFQ 11.55 2.87 .319 .051 .248 .14
NMa 1.48 1.35 .643 \.001 .769 \.001 .258 .12
PMa 5.65 1.63 -.476 .002 -.447 .006 -.169 .31 -.498 .001
HADS-D 2.08 2.27 .140 .40 .276 .098 .205 .22 .320 .050 -.068 .69
CSSS 14.11 7.93 .346 .033 .335 .043 .075 .65 .340 .037 -.012 .94 .476 .003
MomFS Momentary Fatigue Severity; DailyFS Daily Fatigue Severity; CFQ Chalder Fatigue Questionnaire (total score); NM Negative Mood;
PM Positive Mood; HADS-D Hospital Anxiety and Depression Scale–Depression subscale; CSSS Chronic Stress Screening Scale; EDSS
Expanded Disability Status Scale
a Person-mean averages
b RRMS group only
1 Prompted by a reviewer, we examined whether people in the MS
group were more likely to nap in the afternoon, explaining the neg-
ative quadratic effect. Naps (n = 24 in the MS group; n = 8 in the
control group) were not more likely later in the day in either group.
The linear and quadratic effects reported also persisted when
including naps in the model.
J Behav Med (2017) 40:772–783 777
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Severity (p\ .001). Statistically significant interaction
effects with group were evident for both physical exertion
and sleep quality (ps\ .05) indicating substantial between-
group differences.
In the relapsing-remitting MS group, both Lack of Social
Recognition and Work Discontent scores were associated
within-individuals with Momentary Fatigue Severity such
that when either stressor type was higher than usual, sub-
sequent severity was increased (ps\ .05; see Table 5).
These two stressors showed similar effects in controls, with
no significant group differences (see Table 5). Of the
remaining six stressors, none were associated with Mo-
mentary Fatigue Severity in either group. Random effects
of Lack of Social Recognition (p = .44) and Work Dis-
content (p = .13) did not reach statistical significance,
indicated their effects were relatively consistent across
individuals.
In the relapsing-remitting MS group, Negative Mood
and Positive Mood was associated within-individuals with
increased Momentary Fatigue Severity such that severity
was higher when levels of negative mood were higher and
when levels of positive mood were lower (p\ .001; see
Table 5). Similar associations of Negative Mood and
Positive Mood with Momentary Fatigue Severity were
present in the control group (ps\ .001) with no statisti-
cally significant group differences in these associations
(see Table 5). The random effects of Negative Mood
(p = .033) and Positive Mood (p = .001) indicated sub-
stantial variability in the size of these associations across
individuals.
Discussion
As expected, substantial moment-to-moment and day-to-
day fluctuations in fatigue severity were found in relapsing-
remitting MS. Analysis of typical diurnal fatigue patterns
found that, in relapsing-remitting MS diurnal fatigue pat-
terns charted a quicker increase in severity in the earlier
part of the day than controls, peaking in late-afternoon.
Notable differences between individual diurnal patterns
were evident, meaning the described pattern did not
replicate across every person with relapsing-remitting MS.
Healthy individuals generally exhibited a slower, steadier,
accumulation of fatigue across the day. Fatigue in relaps-
ing-remitting MS appears not only higher, but also seems
to peak earlier in the day, than healthy individuals. In line
with our other hypotheses, increased stressor exposure
(specifically, discontent with current work activity, and
lack of social recognition), increased negative mood, and
decreased positive mood were all associated with increases
in fatigue in real-time.
In the relapsing-remitting MS group, we found reason-
ably strong associations of both person-mean real-time
fatigue severity and daily fatigue severity with Chalder
Fatigue Questionnaire scores. However, we have demon-
strated that patient reported outcomes based, implicitly or
Fig. 1 Step line charts (solid lines) depicting change in Momentary
Fatigue Severity ratings in three individuals from the relapsing-
remitting MS group over the six assessments (A1–A6) from four
assessment days. Dashed lines indicate person-means and dotted lines
indicate daily-means. Corresponding within-person indices are
presented, including mean, median (med), mean successive squared
difference (MSSD; Jahng et al., 2008), probability of acute change
(PAC; acute change defined as change C5 units between two adjacent
assessments; Jahng et al., 2008), and proportion of ratings C5
778 J Behav Med (2017) 40:772–783
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explicitly, on mean average severity, overlook potentially-
important information about time- and context-dependent
fluctuations. Real-time data can provide informative indi-
cators of symptom experience to complement the mean
average (Stone et al., 2012). Future trials could consider
demonstrating treatment efficacy by identifying and alle-
viating those aspects of the overall ‘fatigue experience’
deemed most important by the individual (Stone et al.,
2012). For some individuals, one or more inherently
within-person facets of fatigue severity may be of greatest
relevance to quality of life; speculatively, acutely-fluctu-
ating symptoms may cause considerably more uncertainty
(and hinder adaptive adjustment) than stable symptoms.
Fatigue appeared to generally peak in late-afternoon in
the relapsing-remitting MS group, corroborating earlier
qualitative studies (Freal et al., 1984; Mills & Young,
2008). A ceiling effect was considered unlikely here given
the maximum Momentary Fatigue Severity rating was
infrequently used (\3%). Future research may identify trait
or state factors predicting deviations from typical diurnal
fatigue patterns. The present study suggested relapsing-
remitting MS fatigue is not affected by daily changes in
sleep quality, which was surprising given a recent review
found sleep problems in MS contribute to fatigue (Strober,
2015). Given that there is a wealth of literature demon-
strating robust increases in fatigue after a night of sleep
deprivation in other clinical conditions (Irwin et al., 2012;
Nicassio et al., 2002), future studies will need to test this
temporal relationship using an objective measure of sleep
continuity such as polysomnography. A period of physical
exertion increased fatigue in the relapsing-remitting MS
group, resembling post-exertional malaise: an important
symptom in chronic fatigue syndrome that is, broadly, an
acute increase in fatigue (and other symptoms) following
exertion that has an extended recovery time (Carruthers
et al., 2011; Fukuda et al., 1994). However, the exertion
Table 4 Model parameter estimates testing typical diurnal fatigue patterns in the relapsing-remitting MS group and control group, with 95%
confidence intervals in square brackets
Relapsing-remitting MS Control Group comparison
c (SE) [95% CI] p c (SE) [95% CI] p c (SE) [95% CI] p
Fixed effects
Intercept 3.24 (0.37) [2.50, 3.98] \.001 1.44 (0.37) [0.70, 2.18] \.001 1.80 (0.53) [0.75, 2.84] \.001
Time 0.49 (0.11) [0.27, 0.71] \.001 0.27 (0.11) [0.05, 0.49] .015 0.22 (0.16) [-0.10, 0.53] .177
Time2 -0.03 (0.01) [-0.05, -0.01] .012 -0.002 (0.01) [-0.02, 0.02] .83 -0.02 (0.02) [-0.06, 0.01] .10
HADS-D 0.03 (0.13) [-0.22, 0.28] .84 0.07 (0.14) [-0.21, 0.35] .62 -0.04 (0.19) [-0.42, 0.33] .82
CSSS 0.10 (0.03) [0.04, 0.16] .002 0.07 (0.04) [-0.01, 0.15] .070 0.03 (0.05) [-0.07, 0.13] .59
Random effects
Level-3 (Individual)
Intercept 2.44 (0.51) [1.62, 3.67] \.001
Time 0.03 (0.01) [0.02, 0.06] \.001
Level-2 (day)
Intercept 3.16 (0.74) [2.00, 5.00] \.001
Time 0.67 (0.16) [0.42, 1.06] \.001
Time2 0.01 (0.002) [0.004, 0.01] \.001
Level-1 (Assessment)
Residual 1.53 (0.08) [1.39, 1.69] \.001
HADS-D Hospital Anxiety and Depression Scale–Depression subscale; CSSS Chronic Stress Screening Scale. HADS-D and CSSS are grand-
mean centred. Time is centred about 10 am. Level-3 random covariance parameters (unstructured) not presented here, but included in the model
Fig. 2 Average fatigue trajectories over time in the relapsing-
remitting MS group (red solid line) and the control group (green
dashed line). The circular indicators represent unique Momentary
Fatigue Severity assessments in the relapsing-remitting MS group; the
triangular indicators represent those in the control group
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measure in the present study was binary (yes/no) with no
detail about intensity. There is some evidence, albeit
inconsistent across studies, that physical activity has ben-
eficial effects on MS fatigue (Latimer-Cheung et al., 2013)
and a Cochrane review concluded that there is an overall
moderate effect of exercise therapy on reducing fatigue
(Heine et al., 2015). Further research incorporating objec-
tive measures of activity are required to precisely elucidate
the within-person effect of exertion on fatigue in MS, and
to further explore similarities with post-exertional malaise.
The present study adds a within-person perspective to
existing studies demonstrating associations between stress
and fatigue in MS (Trojan et al., 2007). Individuals in both
groups were more fatigued after periods in which they felt
discontented with their current work, or underappreciated
for their efforts. Of the eight stressor types measured, the
two items associated with fatigue (Lack of Social Recog-
nition; Work Discontent) are conceptually linked with
one’s motivation to persist with the current task. These
findings support theoretical developments suggesting gen-
eral fatigue is an emotional experience prompting a (likely
unconscious) re-evaluation of the costs and benefits of
continuing with the present activity, and a redirection of
attention toward other behaviors with greater utility
(Hockey, 2013; Inzlicht et al., 2014; Kurzban et al., 2013).
Crucially, we found no evidence that these stressors, or
mood, had magnified within-person effects on fatigue in
relapsing-remitting MS.
In chronic fatigue syndrome, positive correlations
ranging from small to moderate in size have been found
between person-mean momentary fatigue intensity and
person-mean negative affect, depression, anxiety, and
catastrophizing (Sohl & Friedberg, 2008). In the present
study, person-mean correlations between negative mood
and fatigue severity were not statistically significant in the
relapsing-remitting MS group, but a large correlation was
found in the control group, again indicating that MS-related
fatigue is a different phenomenon to the fatigue experi-
enced by healthy individuals. This was despite average
levels of negative mood being higher in the MS group than
controls. Moderate and negative correlations with person-
mean positive mood were evident in both groups, and was
not experienced less frequently in the relapsing-remitting
MS group.
The described real-time contextual associations do not
infer direct causality (although stressors measured ‘since
the last event’ imply pooled stressors over that period
occurred before fatigue ‘right now’) and a lagged-effects
analysis with a more-intensive ecological momentary
assessment schedule may further explain directions of
effects.
The limited reliability of the stressor factor scores was
likely due to the low frequency of stressors observed,
resulting in heavily skewed distributions, and the relatively
small number of items contributing to each factor. Multiple
testing with individual stressor items increased the risk of
Table 5 Model fixed effect parameter estimates of within-person behavioural and psychosocial contextual effects with 95% confidence intervals
in square brackets
Relapsing-remitting MS Control Group comparison
c (SE) [95% CI] p c (SE) [95% CI] p c (SE) [95% CI] p
Model B—Behavioural
Physical exertion 1.00 (0.21) [0.58, 1.42] \.001 0.23 (0.24) [-0.24, 0.70] .33 0.77 (0.32) [0.14, 1.39] .017
Sleep quality -0.02 (0.04) [-0.11, 0.06] .59 -0.18 (0.05) [-0.29, -0.07] .001 0.16 (0.07) [0.02, 0.29] .028
Model C—Stressors
Work overload 0.02 (0.03) [-0.03, 0.08] .38 -0.02 (0.02) [-0.06, 0.03] .52 0.04 (0.04) [-0.03, 0.11] .28
Social overload 0.03 (0.03) [-0.03, 0.09] .31 0.03 (0.02) [-0.02, 0.07] .26 0.001 (0.04) [-0.07, 0.07] .99
Excessive demands at work 0.02 (0.03) [-0.04, 0.09] .47 0.06 (0.04) [-0.02, 0.13] .14 -0.03 (0.05) [-0.13, 0.07] .54
Lack of social recognition 0.08 (0.04) [0.01, 0.15] .025 0.09 (0.05) [-0.002, 0.19] .056 -0.01 (0.06) [-0.13, 0.11] .84
Work discontent 0.06 (0.03) [0.001, 0.12] .046 0.11 (0.03) [0.05, 0.16] \.001 -0.05 (0.04) [-0.13, 0.03] .25
Social tensions 0.01 (0.03) [-0.06, 0.08] .71 0.02 (0.04) [-0.06, 0.10] .60 -0.01 (0.05) [-0.11, 0.09] .89
Pressure to perform -0.02 (0.03) [-0.07, 0.03] .46 0.01 (0.02) [-0.04, 0.06] .71 -0.03 (0.04) [-0.10, 0.04] .43
Social isolation 0.01 (0.03) [-0.04, 0.06] .64 -0.01 (0.03) [-0.05, 0.04] .83 0.02 (0.04) [-0.05, 0.09] .63
Model D—Mood
Negative mood 0.17 (0.05) [0.09, 0.26] \.001 0.23 (0.05) [0.13, 0.34] \.001 -0.06 (0.07) [-0.20, 0.08] .42
Positive mood -0.37 (0.04) [-0.46, -0.28] \.001 -0.35 (0.05) [-0.45, -0.25] \.001 -0.02 (0.07) [-0.15, 0.11] .78
Model intercepts and fixed effects of time, time2, Hospital Anxiety and Depression Scale–Depression subscale score, Chronic Stress Screening
Scale score, and the random effects of intercept, time, and time2 are not shown
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spurious findings, but was considered unlikely here given
statistically significant effects were consistent across
groups. Nevertheless, the exploratory nature of these
stressor effects is emphasized.
Participant compliance was excellent, with few missing
assessments. The quasi-random design minimized prompt
anticipation, and yielded a representative sample of daily
living (Broderick et al., 2008). Prompts between 10 am and
8 pm were chosen to limit the possibility that fatigue mea-
sures would be confounded by sleepiness, considered a dis-
tinct phenomenon (Shen et al., 2006). However,
understanding of early-morning fatigue is therefore limited.
Weekday-weekend differences in fatigue may also be wor-
thy of investigation in future studies in MS. The recruited
sample was relatively homogeneous, with no comorbidities,
and most were still full-time employed. Further investiga-
tions could explore the generalizability of the findings to
people with relapsing-remitting MS and common comor-
bidities, such as depression, and to people with progressive
MS-types. Future studies may also compare fatigue trajec-
tories in MS to those found in other conditions with char-
acteristic chronic fatigue, such as cancer or fibromyalgia, or
to chronic fatigue syndrome itself.
The study has some limitations. A concern with eco-
logical momentary assessment studies is that intensive self-
monitoring may change the experience of the symptom
being monitored: a process known as measurement reac-
tivity (Barta et al., 2012). While there is no or negligible
evidence of measurement reactivity in many empirical
investigations of the phenomenon (for example, Aaron
et al., 2005; Peters et al., 2000; Sonnenschein et al., 2006;
Stone et al., 2003) it has been noted that more work is
needed to explore this phenomenon in other domains,
including fatigue (Barta et al., 2012). Here, Momentary
Fatigue Severity combined physical with mental fatigue
into a single item measuring general fatigue severity. It
may be informative for future studies to examine physical
and mental fatigue in daily life separately; however, a
recent psychometric analysis of the Chalder Fatigue
Questionnaire in MS found one general fatigue factor
accounted for 81.4% of variance in a bi-factor model,
suggesting a limited practical distinction between physical
and mental fatigue constructs (Chilcot et al., 2015).
This study is the first prospective investigation of tem-
poral and contextual effects on real-time fatigue severity in
relapsing-remitting MS: typically, fatigue increased over
the day but decelerated toward a peak in late-afternoon,
while contextual associations with specific stressors and
mood were evident. Findings suggest future MS fatigue
interventions could explore ways of improving positive
mood and responding to interpersonal and work stressors
differently. Ways to manage peak fatigue in the afternoon
and after physical exertion should be explored, possibly
using scheduled rest breaks or short naps (less than 30 min)
in accordance with current guidance (Multiple Sclerosis
Council for Clinical Practice Guidelines, 2000). Notably,
temporal effects and associations with momentary mood
varied substantially across individuals. Increasing our
understanding of how fatigue is dynamically experienced
by each individual may present opportunities to further
develop tailored interventions targeting fatigue.
Acknowledgements The preparation of this manuscript was sup-
ported by a UK Economic and Social Research Council (ESRC) Ph.D.
studentship (ES/1026266/1) awarded to DP. The study was funded by
the Psychology Unit at the University of Southampton. The authors
declare that they have no conflict of interest. The authors thank all
participants of this study.
Compliance with ethical standards
Conflict of interest Daniel J. H. Powell, Christina Liossi, Wolff
Schlotz, and Rona Moss-Morris declares that they have no conflict of
interest.
Human and animal rights and Informed consent All procedures
followed were in accordance with ethical standards of the responsible
committee on human experimentation (institutional and national) and
with the Helsinki Declaration of 1975, as revised in 2000. Informed
consent was obtained from all patients for being included in the study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Aaron, L. A., Turner, J. A., Mancl, L., Brister, H., & Sawchuk, C. N.
(2005). Electronic diary assessment of pain-related variables: Is
reactivity a problem? The Journal of Pain, 6(2), 107–115.
doi:10.1016/j.jpain.2004.11.003
Barta, W. D., Tennen, H., & Litt, M. D. (2012). Measurement
reactivity in diary research. In M. R. Mehl & T. S. Conner (Eds.),
Handbook of research methods for studying daily life. New
York, NY: Guilford Press.
Black, A. C., Harel, O., & Matthews, G. (2012). Techniques for
analyzing intensive longitudinal data with missing values. In M.
R. Mehl & T. S. Conner (Eds.), Handbook of research methods
for studying daily life. New York, NY: The Guilford Press.
Bowen, J., Gibbons, L., Gianas, A., & Kraft, G. H. (2001). Self-
administered expanded disability status scale with functional
system scores correlates well with a physician-administered test.
Multiple Sclerosis, 7(3), 201–206.
Broderick, J. E., Schwartz, J. E., Vikingstad, G., Pribbernow, M.,
Grossman, S., & Stone, A. A. (2008). The accuracy of pain and
fatigue items across different reporting periods. Pain, 139(1),
146–157.
Carruthers, B. M., van de Sande, M. I., De Meirleir, K. L., Klimas, N.
G., Broderick, G., Mitchell, T., et al. (2011). Myalgic
encephalomyelitis: International consensus criteria. Journal of
Internal Medicine, 270(4), 327–338.
J Behav Med (2017) 40:772–783 781
123
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S.,
Wright, D., et al. (1993). Development of a fatigue scale.
Journal of Psychosomatic Research, 37(2), 147–153.
Chilcot, J., Norton, S., Kelly, M. E., & Moss-Morris, R. (2015). The
Chalder Fatigue Questionnaire is a valid and reliable measure of
perceived fatigue severity in multiple sclerosis. Multiple Sclero-
sis Journal, 22(5), 677–684.
Claros-Salinas, D., Bratzke, D., Greitemann, G., Nickisch, N., Ochs,
L., & Schro¨ter, H. (2010). Fatigue-related diurnal variations of
cognitive performance in multiple sclerosis and stroke patients.
Journal of the Neurological Sciences, 295(1–2), 75–81.
Feys, P., Gijbels, D., Romberg, A., Santoyo, C., Gebara, B., Maertens
de Noordhout, B., et al. (2012). Effect of time of day on walking
capacity and self-reported fatigue in persons with multiple
sclerosis: A multi-center trial. Multiple Sclerosis Journal, 18(3),
351–357.
Freal, J. E., Kraft, G. H., & Coryell, J. K. (1984). Symptomatic
fatigue in multiple sclerosis. Archives of Physical Medicine and
Rehabilitation, 65(3), 135–138.
Fukuda, K., Straus, S., Hickie, I., Sharpe, M., Dobbins, J., &
Komaroff, A. (1994). The chronic fatigue syndrome: A com-
prehensive approach to its definition and study. Annals of
Internal Medicine, 121(12), 953–959. doi:10.7326/0003-4819-
121-12-199412150-00009.
Geldhof, G. J., Preacher, K. J., & Zyphur, M. J. (2014). Reliability
estimation in a multilevel confirmatory factor analysis frame-
work. Psychological Methods, 19(1), 72–91.
Gledhill, J. (2005). A qualitative study of the characteristics and
representation of fatigue in a French speaking population of
cancer patients and healthy subjects. European Journal of
Oncology Nursing, 9(4), 294–312. doi:10.1016/j.ejon.2004.11.
002
Hadjimichael, O., Vollmer, T., & Oleen-Burkey, M. (2008). Fatigue
characteristics in multiple sclerosis: The North American
Research Committee on Multiple Sclerosis (NARCOMS) sur-
vey. Health and Quality of Life Outcomes, 6, 100.
Heine, M., van de Port, I., Rietberg, M. B., van Wegen, E. E., &
Kwakkel, G. (2015). Exercise therapy for fatigue in multiple
sclerosis. The Cochrane Library, 9, CD009956.
Hockey, R. (2013). The psychology of fatigue: Work, effort and
control. Cambridge: Cambridge University Press.
Honarmand, K., & Feinstein, A. (2009). Validation of the Hospital
Anxiety and Depression Scale for use with multiple sclerosis
patients. Multiple Sclerosis, 15(12), 1518–1524. doi:10.1177/
1352458509347150
Inzlicht, M., Schmeichel, B. J., & Macrae, C. N. (2014). Why self-
control seems (but may not be) limited. Trends in Cognitive
Sciences, 18(3), 127–133.
Irwin, M. R., Olmstead, R., Carrillo, C., Sadeghi, N., FitzGerald, J.
D., Ranganath, V. K., et al. (2012). Sleep loss exacerbates
fatigue, depression, and pain in rheumatoid arthritis. Sleep,
35(4), 537–543.
Jahng, S., Wood, P. K., & Trull, T. J. (2008). Analysis of affective
instability in ecological momentary assessment: Indices using
successive difference and group comparison via multilevel
modeling. Psychological Methods, 13(4), 354–375.
Kluger, B. M., Krupp, L. B., & Enoka, R. M. (2013). Fatigue and
fatigability in neurologic illnesses: Proposal for a unified
taxonomy. Neurology, 80(4), 409–416.
Kos, D., Kerckhofs, E., Nagels, G., D’hooghe, M. B., & Ilsbroukx, S.
(2008). Origin of fatigue in multiple sclerosis: Review of the
literature. Neurorehabilitation and Neural Repair, 22(1),
91–100. doi:10.1177/1545968306298934
Kurtzke, J. F. (1983). Rating neurologic impairment in multiple
sclerosis. Neurology, 33(11), 1444–1452.
Kurzban, R., Duckworth, A., Kable, J. W., & Myers, J. (2013). An
opportunity cost model of subjective effort and task perfor-
mance. Behavioral and Brain Sciences, 36(06), 661–679.
Latimer-Cheung, A. E., Pilutti, L. A., Hicks, A. L., Martin Ginis, K.
A., Fenuta, A. M., MacKibbon, K. A., et al. (2013). Effects of
exercise training on fitness, mobility, fatigue, and health-related
quality of life among adults with multiple sclerosis: A systematic
review to inform guideline development. Archives of Physical
Medicine and Rehabilitation, 94(9), 1800–1828.
Lerdal, A., Celius, E. G., & Moum, T. (2003). Fatigue and its
association with sociodemographic variables among multiple
sclerosis patients. Multiple Sclerosis, 9(5), 509–514.
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M.,
Johnson, B. A., Wendt, J. K., et al. (1999). The rapid assessment
of fatigue severity in cancer patients. Cancer, 85(5), 1186–1196.
Mills, R. J., & Young, C. A. (2008). A medical definition of fatigue in
multiple sclerosis. QJM, 101(1), 49–60.
Minden, S. L., Frankel, D., Hadden, L., Perloffp, J., Srinath, K. P., &
Hoaglin, D. C. (2006). The Sonya Slifka longitudinal multiple
sclerosis study: Methods and sample characteristics. Multiple
Sclerosis, 12(1), 24–38.
Mollaog˘lu, M., & U¨stu¨n, E. (2009). Fatigue in multiple sclerosis
patients. Journal of Clinical Nursing, 18(9), 1231–1238.
Morris, M. E., Cantwell, C., Vowels, L., & Dodd, K. (2002). Changes
in gait and fatigue from morning to afternoon in people with
multiple sclerosis. Journal of Neurology, Neurosurgery and
Psychiatry, 72(3), 361–365.
Multiple Sclerosis Council for Clinical Practice Guidelines. (1998).
Fatigue and multiple sclerosis: Evidence-based management
strategies for fatigue in multiple sclerosis. Washington, DC:
Paralyzed Veterans of America.
Multiple Sclerosis Council for Clinical Practice Guidelines. (2000).
Fatigue: What you should know. Washington, DC: Paralyzed
Veterans of America.
Nicassio, P. M., Moxham, E. G., Schuman, C. E., & Gevirtz, R. N.
(2002). The contribution of pain, reported sleep quality, and
depressive symptoms to fatigue in fibromyalgia. Pain, 100(3),
271–279.
Peters, M. L., Sorbi, M. J., Kruise, D. A., Kerssens, J. J., Verhaak, P.
F. M., & Bensing, J. M. (2000). Electronic diary assessment of
pain, disability and psychological adaptation in patients differing
in duration of pain. Pain, 84(2–3), 181–192. doi:10.1016/S0304-
3959(99)00206-7
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A.,
Filippi, M., et al. (2011). Diagnostic criteria for multiple
sclerosis: 2010 Revisions to the McDonald criteria. Annals of
Neurology, 69(2), 292–302.
Powell, D. J. H., Moss-Morris, R., Liossi, C., & Schlotz, W. (2015).
Circadian cortisol and fatigue severity in relapsing-remitting
multiple sclerosis. Psychoneuroendocrinology, 56, 120–131.
Powell, D. J. H., & Schlotz, W. (2012). Daily life stress and the
cortisol awakening response: testing the anticipation hypothesis.
PLoS ONE, 7(12), e52067.
Schulz, P., Schlotz, W., & Becker, P. (2004). Trierer Inventar zum
Chronischen Stress (TICS) [Trier Inventory for Chronic Stress
(TICS)]. Gottingen: Hogrefe Verlag.
Shen, J., Barbera, J., & Shapiro, C. M. (2006). Distinguishing
sleepiness and fatigue: focus on definition and measurement.
Sleep Medicine Reviews, 10(1), 63–76.
Shiffman, S., Stone, A. A., & Hufford, M. R. (2008). Ecological
momentary assessment. Annual Review of Clinical Psychology,
4, 1–32.
Singer, J. D., & Willett, J. B. (2003). Applied Longitudinal Data
Analysis: Modelling Change and Event Occurrence. New York,
NY: Oxford University Press.
782 J Behav Med (2017) 40:772–783
123
Sohl, S. J., & Friedberg, F. (2008). Memory for fatigue in chronic
fatigue syndrome: relationships to fatigue variability, catastro-
phizing, and negative affect. Behavioral Medicine, 34(1), 29–38.
Sonnenschein, M., Sorbi, M. J., van Doornen, L. J. P., & Maas, C.
J. M. (2006). Feasibility of an electronic diary in clinical
burnout. International Journal of Behavioral Medicine, 13(4),
315–319. doi:10.1207/s15327558ijbm1304_6
Stone, A. A., Broderick, J. E., Schneider, S., & Schwartz, J. E. (2012).
Expanding options for developing outcome measures from
momentary assessment data. Psychosomatic Medicine, 74(4),
387–397.
Stone, A. A., Broderick, J. E., Schwartz, J. E., Shiffman, S., Litcher-
Kelly, L., & Calvanese, P. (2003). Intensive momentary
reporting of pain with an electronic diary: Reactivity, compli-
ance, and patient satisfaction. Pain, 104(1–2), 343–351. doi:10.
1016/s0304-3959(03)00040-x
Strober, L. B. (2015). Fatigue in multiple sclerosis (MS): A look at
the role of poor sleep. Frontiers in Neurology, 6(21), 1–7.
Strober, L. B., & Arnett, P. A. (2005). An examination of four models
predicting fatigue in multiple sclerosis. Archives of Clinical
Neuropsychology, 20(5), 631–646. doi:10.1016/j.acn.2005.04.
002
Stroud, N. M., & Minahan, C. L. (2009). The impact of regular
physical activity on fatigue, depression and quality of life in
persons with multiple sclerosis. Health and Quality of Life
Outcomes, 7(1), 68.
Stuifbergen, A. K., & Rogers, S. (1997). The experience of fatigue
and strategies of self-care among persons with multiple sclerosis.
Applied Nursing Research, 10(1), 2–10.
Trojan, D. A., Arnold, D., Collet, J.-P., Shapiro, S., Bar-Or, A.,
Robinson, A., et al. (2007). Fatigue in multiple sclerosis:
Association with disease-related, behavioural and psychosocial
factors. Multiple Sclerosis, 13(8), 985–995.
Tyson, S. F., & Brown, P. (2014). How to measure fatigue in
neurological conditions? A systematic review of psychometric
properties and clinical utility of measures used so far. Clinical
Rehabilitation, 28(8), 804–816.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and
depression scale. Acta Psychiatrica Scandinavica, 67(6),
361–370.
J Behav Med (2017) 40:772–783 783
123
